2 Healthcare Stocks to Buy for 2026 and Beyond

2026-01-08 05:35:00 ET

The healthcare sector underperformed broader equities in 2025, but that shouldn't deter investors. Many companies in the industry performed relatively well and appear to be solid buy-and-hold options.

And we're not just talking about the most prominent, best-known healthcare leaders on the market. Plenty of smaller players in the field are worth serious consideration, too.

Let's consider two such companies in the biotech industry: Axsome Therapeutics (NASDAQ: AXSM) and Exelixis (NASDAQ: EXEL) . Here's why both are worth investing in and holding on to through 2026 and beyond.

Continue reading